Released May 7, 2015, after the close
10-Q filed May 7, 2015, 37 days after period end · 0001390478-15-000024
Q1 2015 · 10-Q
Revenue$2.75M$2.75M +26.6% vs Q1 2014−13.9% vs Q4 2014
Net Income-$10.54M-$10.54M N/M vs Q1 2014N/M vs Q4 2014
EPS Diluted-$0.08-$0.08 N/M vs Q1 2014no prior Q4 2014 on file
Operating Income-$8,912,000N/M
Operating Cash Flow-$11,556,000N/M
Free Cash Flowderived-$11,574,000N/M
Margins · derived
Operating margin-324.1%+221.2 pt vs Q1 2014
Net margin-383.2%−266.5 pt vs Q1 2014
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q1 2015 | Q1 2014 | Q1 2013 | Q1 2012 |
|---|---|---|---|---|
| Revenue | $2.75M | $2.17M | $2.75M | $2.75M |
| Net Income | -$10.54M | -$2.54M | -$16.49M | -$10.54M |
| EPS Diluted | -$0.08 | -$0.02 | -$0.11 | -$0.52 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
SELLAS Life Sciences Group, Inc. · CIK 1390478 · Engraved from SEC EDGAR